Under construction – not a live service
Sign in
Taking peopleNo phase

Hip Abductor Strengthening Exercises in Knee Osteoarthritis

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 40 and 60 years old?

Source: NCT06845657, who can take part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Riphah International University
Trial code
NCT06845657
Record updated
11 March 2025
Original description
The aim of this randomized controlled trial is to find the effect of hip abductor strengthening exercises on pain, range of motion, functional disability and balance in patient with knee osteoarthritis.Read full original descriptionShow less

Effect of Hip Abductor Strengthening Exercises in Patients With Knee Osteoarthritis

The aim of this randomized controlled trial is to find the effect of hip abductor strengthening exercises on pain, range of motion, functional disability and balance in patient with knee osteoarthritis.

Inclusion: • Age group 40-60; Both genders male and female; Have had knee pain for 3 months or more; Report a minimum average overall pain severity of 4 on an 11-point numeric rating scale (NPRS) over the previous week; grade II and III on X-ray (Kellgren and Lawrence classification); For participants with bilateral knee osteoarthritis, the more seriously affected side (as identified by the Kellgren-Lawrence grade of knee osteoarthritis and the pain intensity) was selected as the affected leg; willing to participate in intervention program.

Exclusion: • history of surgery of lower limb; Past knee fracture or malignancy; individuals with known hip OA and/or previous trauma affecting one or both hips; Intraarticular corticosteroid injection into the knee within previous 3 months; Pregnancy.

ClinicalTrials.gov NCT06845657